RxDoctor Payments Data

Robert Falcone

Occupational Medicine · Whitehouse Station, NJNPI 1194846113

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $900 of the $1,190 with a category attached, or 75.6%. Eli Lilly accounts for 75.6% of it on its own, with 2 other manufacturers making up the rest.

$1,190in general payments, 2019–2025

Across 3 payments — averaging $396.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$900
  • Bayer$270
  • Pfizer$20
$27,777,906in research payments, 2019–2025

Across 1,734 payments — averaging $16,020 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$14M
  • Pfizer$7.8M
  • AbbVie$1.6M
  • Intercept Pharmaceuticals, Inc.$1.4M
  • Biontech SE$1M
  • Modernatx, Inc.$592K
  • plus $1.3M from 12 others

What the payments were for

  • Consulting fees$27023%
  • Speaking & faculty fees$90076%
  • Gifts$202%

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly1$900
Bayer1$270
Pfizer1$20

How this compares

Too few occupational medicine providers in New Jerseyto place this figure against a meaningful peer group, so we don't.

Other occupational medicine in Whitehouse Station

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →